Purchase Order 19CB6019P0949

This is a $24,917.48 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for RNA isolation services. The contract is not set aside and has an ultimate completion date of June 11, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided various products and services...

This firm-fixed-price purchase order was awarded to Qiagen, LLC by the Centers for Disease Control and Prevention (CDC) to provide next-generation sequencing of pulmonary microRNA. The $24,994.80 contract has a performance period ending on September 30, 2023. Qiagen, a division of the parent company Qiagen N.V., is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The company has a history of providing a range of goods...

This purchase order awarded by the Defense Intelligence Agency is for $148,043.12 to procure RNA extraction kits with a completion date of June 30, 2020. The award was made on June 12, 2020 to Miscellaneous Foreign Awardees, a for-profit organization registered to do business as Federal Egov IAE Initiative - Generic Entity Identifier, with performance in Nepal. No set-aside designation was used given the awardee's status as a foreign entity. The RNA extraction kits will support coronavirus...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for the delivery of NI-NTA Superflow Agarose Kits. The contract has a ceiling value of $4,636.45 and a completion date of December 16, 2015. Qiagen, LLC is a division of the multinational biotechnology company Qiagen N.V. and has provided various products and services to federal agencies,...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a subsidiary of Qiagen N.V., for the delivery of PAXGENE 96 BLOOD RNA KIT (4). The contract has an ultimate completion date of April 4, 2014 and a ceiling value of $3,020.16. Qiagen is a large, international biotechnology company that provides a range of products and services to support federal agencies' biomedical research, public health, law...

This is a delivery order contract awarded by the U.S. Army Medical Command to Qiagen, LLC, a subsidiary of Qiagen N.V., for a MERCURY LNA miRNA Focus PCR Panel. The contract has a firm fixed price of $25,771.92 and a completion date of August 26, 2022. Qiagen is a multinational biotechnology company that provides a wide range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, bioinformatics software, and...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Qiagen, LLC. The $22,564.76 order is for Qiagen's AMBIS 1639815 - miScript miRNA PCR Array Human miRNome kit, a product used for microRNA analysis. Qiagen, a global biotechnology company, has provided various molecular diagnostics products and services to federal agencies supporting...

This federal contract award, with a value of $24,765.03, was issued by the Food and Drug Administration (FDA) to Qiagen Sciences LLC, a foreign-owned, for-profit organization that specializes in providing laboratory reagents, DNA analysis kits, software licenses, and other biotechnology products to various U.S. government agencies. The contract is for RNA-SEQUENCING and has a Firm Fixed Price pricing type with an ultimate completion date of December 31, 2024. Qiagen Sciences LLC is a...

This is a firm fixed-price purchase order contract awarded by the Southeast Area (a Civilian agency) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics products. The $24,086.89 contract is for the supply of the Quantitect Reverse Transcription Kit, which will be used for a Population Viral Library Identification/Irradiation Project. The award was made on July 13, 2016, with a completion date of August 1, 2016. This contract does not have a set-aside designation....

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $41,687.04 firm-fixed-price purchase order is for the QIAAMP Viral RNA Mini Kit (250), which is used for the extraction and purification of viral RNA. This award is not associated with any set-aside designation. Qiagen has...